Concepedia

Christopher Harbison

CH

57

Publications

39.8K

Citations

39

H-Index

2001

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Memorial Sloan Kettering Cancer Center

Sidney Kimmel Comprehensive Cancer Center

Moffitt Cancer Center

Yale Cancer Center

Christopher Harbison is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2001–2021

57

Publications

57

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.3K citations · Full text

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Paul Baas et al. · New England Journal of Medicine · 2015 · 8.4K citations · Full text

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Alexandra Snyder, Vladimir Makarov, Taha Merghoub et al. · New England Journal of Medicine · 2014 · 4.3K citations · Full text

Transcriptional Regulatory Networks in <i>Saccharomyces cerevisiae</i>

Tong Ihn Lee, Nicola J. Rinaldi, François Robert et al. · Science · 2002 · 3K citations

, , +20

Transcriptional regulatory code of a eukaryotic genome

Christopher Harbison, D. Benjamin Gordon, Tong Ihn Lee et al. · Nature · 2004 · 2.2K citations · Full text

, , +8

Rows per page

1–5 of 57